CRYO-CELL INTERNATIONAL, INC. (CCEL) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 8.06M; Formula and calculation Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 8.06M | Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-06-30. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 8.06M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-05-31 | 8.06M | (m) | (m) |
| 2026-02-28 | 8.06M | (m) | (m) |
| 2025-08-31 | 8.06M | (m) | (m) |
| 2025-05-31 | 8.06M | (m) | (m) |
| 2025-02-28 | 8.08M | (m) | (m) |
| 2024-11-30 | 8.08M | (m) | (m) |
| 2024-08-31 | 8.06M | (m) | (m) |
| 2024-05-31 | 8.06M | (m) | (m) |
| 2024-02-29 | 8.10M | (m) | (m) |
| 2023-08-31 | 8.29M | (m) | (m) |
| 2023-05-31 | 8.29M | (m) | (m) |
| 2023-02-28 | 8.30M | (m) | (m) |
| 2022-11-30 | 8.44M | (m) | (m) |
| 2022-05-31 | 8.39M | (m) | (m) |
| 2022-02-28 | 8.46M | (m) | (m) |
| 2021-08-31 | 8.53M | (m) | (m) |
| 2021-05-31 | 8.45M | (m) | (m) |
| 2021-02-28 | 7.98M | (m) | (m) |
| 2020-11-30 | 7.57M | (m) | (m) |
| 2020-08-31 | 7.55M | (m) | (m) |
| 2020-05-31 | 7.55M | (m) | (m) |
| 2020-02-29 | 7.55M | (m) | (m) |
| 2019-11-30 | 7.55M | (m) | (m) |
| 2019-08-31 | 7.80M | (m) | (m) |
| 2019-05-31 | 7.80M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |